Aaa

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

neuroprof

Full Member
10+ Year Member
Joined
Mar 8, 2010
Messages
11
Reaction score
1
Aaa

Members don't see this ad.
 
Last edited:
I don’t think we’re supposed to discuss medical/veterinary advice on SDN?

If you’re a pet owner, I’d recommend talking to your veterinarian or seeking referral to a neurologist to discuss your concerns. If you happen to be a pharmacist, I’d talk to the veterinarians who prescribe the medications over random people on an Internet forum.

My only comments regarding the paper you cite is that the patient demographic that presents for referral veterinary care for seizures and gets written about is often more severe, more complex cases that people are having difficulty managing. So while studies like this are important, things may be different in that patient set compared to “average” seizure dogs in general practice. You have to critically evaluate study design and see if you think their conclusions are valid and applicable. Their study states that >90% were receiving other AEDs and there’s a whole section about dogs that had even more drugs added in, so I don’t think they’re advocating for monotherapy.
 
Last edited:
I ask these questions because some clinical trial data have shown that Keppra loses its effectiveness after 6 months or so of consistent daily use. Some research has shown that using the pulse method may extend its effectiveness over time.
Is this a human vs veterinary study to begin with?

Regardless, why would we wait for them to have seizures at all, rather than try to actively prevent them?
 
Members don't see this ad :)
I don’t think we’re supposed to discuss medical/veterinary advice on SDN?
We have reviewed this post and as it currently is written, it is not requesting medical advice.

My only comments regarding the paper you cite is that the patient demographic that presents for referral veterinary care for seizures and gets written about is often more severe, more complex cases that people are having difficulty managing. So while studies like this are important, things may be different in that patient set compared to “average” seizure dogs in general practice. You have to critically evaluate study design and see if you think their conclusions are valid and applicable. Their study states that >90% were receiving other AEDs and there’s a whole section about dogs that had even more drugs added in, so I don’t think they’re advocating for monotherapy.
^^ just retweeting this.
 
1. I sometimes use Keppra as initial monotherapy in dogs, mainly because it's well tolerated. The exception is small dogs, because TID dosing is a problem for a lot of clients.

2. I've used keppra as short-term treatment for clusters in dogs on maintenance
therapy with other drugs.

3. The "honeymoon" effect is not unique to Keppra. Many seizure drugs will work for a while and then the seizures return. In dogs that tend to suffer clusters/status, I almost always recommend they be on daily seizure medication.
 
Top